Diabetes Mellitus, Type 2 Clinical Trial
— PAT-DM2Official title:
Effects of Progressive vs. Non-progressive Water-based Aerobic Training on Type 2 Diabetes Control: a Randomized Clinical Trial
This is a randomized clinical trial with the aim to evaluate the effects of two water-based aerobic training programs (walking or running in shallow pool) on type 2 diabetes control. The sample will be composed by 50 individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years, who will be randomized into water-based progressive aerobic training (PAT, n=25) and water-based non-progressive aerobic training (NPAT, n=25). Both trainings will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each). Biochemical, cardiorespiratory fitness, maximum strength, body composition and functional mobility variables, as also quality of life, sleep quality and depressive symptoms will be analyzed before and after the 12 weeks of training.
| Status | Not yet recruiting |
| Enrollment | 50 |
| Est. completion date | November 15, 2019 |
| Est. primary completion date | October 30, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years. - Be under medical treatment with oral hypoglycemic agents and / or insulin; - Not be engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week). Exclusion Criteria: - Presence of: - uncontrolled hypertension; - autonomic neuropathy; - severe peripheral neuropathy; - proliferative diabetic retinopathy; - severe non-proliferative diabetic retinopathy; - uncompensated heart failure; - peripheral amputations; - chronic kidney failure; - body mass index (BMI)> 45.0 kg/m2; - to have some muscle or joint impairment that prevents the performance of physical exercises safely. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Federal University of Rio Grande do Sul | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Glycated Hemoglobin levels (HbA1c) | Blood samples will be used to analyze glycated hemoglobin levels (%) | Change from baseline levels of glycated hemoglobin to 12 weeks of intervention. | |
| Secondary | Fasting plasma glucose | in mg/dL | At baseline and after a 12-week period | |
| Secondary | Fasting insulin | in mg/dL | At baseline and after a 12-week period | |
| Secondary | Insulin-resistance index (HOMA-IR) | in amount | At baseline and after a 12-week period | |
| Secondary | Total cholesterol | in mg/dL | At baseline and after a 12-week period | |
| Secondary | High density lipoprotein | in mg/dL | At baseline and after a 12-week period | |
| Secondary | Low density lipoprotein | in mg/dL | At baseline and after a 12-week period | |
| Secondary | Triglycerides | in mg/dL | At baseline and after a 12-week period | |
| Secondary | Plasma renin | in uIU/mL (microliter) | At baseline and after a 12-week period | |
| Secondary | C-reactive protein | in mg/L | At baseline and after a 12-week period | |
| Secondary | Peak oxygen uptake | in ml.kg.min-1 | At baseline and after a 12-week period | |
| Secondary | Oxygen uptake at the second ventilatory threshold. | in ml.kg.min-1 | At baseline and after a 12-week period | |
| Secondary | Percentage of oxygen consumption in the second ventilatory threshold from the peak oxygen uptake | in % | At baseline and after a 12-week period | |
| Secondary | Systolic blood pressure. | in mmHg | At baseline and after a 12-week period | |
| Secondary | Diastolic blood pressure. | in mmHg | At baseline and after a 12-week period | |
| Secondary | Resting heart rate | in beats per minute | At baseline and after a 12-week period | |
| Secondary | Maximum dynamic muscle strength (1RM) in the knees extension exercise | The test is characterized by greatest load that can be supported in a single execution of knees extension exercise. | At baseline and after a 12-week period | |
| Secondary | Muscular resistance (maximal repetitions) in the knees extension exercise. | To determine muscular resistance, it will be considered the number of repetitions performed at 60% of 1RM, following a paced pre-established execution. In the post-training evaluation, we will use the load of 60% of 1RM test performed in the pre-training. | At baseline and after a 12-week period | |
| Secondary | Timed up-and-go test performed at the usual speed. | In seconds | At baseline and after a 12-week period | |
| Secondary | Timed up-and-go test performed at the maximal speed. | In seconds | At baseline and after a 12-week period | |
| Secondary | Overall quality of life and in physical, psychological, social relationships and environment domains, evaluated by instrument of World Health Organization (WHOQOL). | To evaluate the quality of life we used the WHOQOL-brief instrument. This instrument is self-applicable, cross-cultural, translated and validated for Portuguese, consisting of 26 questions. Its score ranges from zero to 100 points, divided into the physical, psychological, social relationships and environment, as well as an assessment of the overall quality of life. | At baseline and after a 12-week period | |
| Secondary | Depressive symptoms, evaluated by Depression Inventory Patient Health Questionnaire (PHQ-9) | For evaluation of depressive symptoms was used the questionnaire PHQ-9 depression, which consists of nine items, including symptoms and attitudes whose intensity varies from zero to three, with 27 being the higher score. | At baseline and after a 12-week period | |
| Secondary | Sleep quality, evaluated by Pittsburgh Sleep Scale | Sleep quality was assessed by Pittsburgh scale, consisting of 19 questions on the perception of oneself and five questions relating to the perception that the roommates of these individuals have about sleep the same. These questions are grouped into seven components, with score of zero to three. | At baseline and after a 12-week period | |
| Secondary | Physical activity levels, evaluated by International Physical Activity Questionnaire (IPAQ) - Long Form. | The IPAQ asks about three specific types of activity undertaken in the three domains introduced above and sitting time. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous intensity activities; frequency (measured in days per week) and duration (time per day) are collected separately for each specific type of activity. | At baseline and after a 12-week period |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |